DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Codeprex Pennkinetic (Codeine Polistirex / Chlorpheniramine Polistirex) - Indications and Dosage

 
 



INDICATIONS AND USAGE

Codeprex is indicated for the temporary relief of cough, as may occur with the common cold or inhaled irritants, and for the temporary relief of runny nose, sneezing, itching of the nose or throat, and itchy watery eyes due to hay fever, other upper respiratory allergies, or allergic rhinitis.

DOSAGE AND ADMINISTRATION

Shake well before using.

Adults and adolescents, ages 12 and older: Two teaspoonfuls (10 mL) every 12 hours; do not exceed four teaspoonfuls in 24 hours.

Children ages 6 to under 12: One teaspoonful (5 mL) every 12 hours; do not exceed two teaspoonfuls in 24 hours.

Not recommended for patients under 6 years of age (see WARNINGS and PRECAUTIONS).

HOW SUPPLIED

Codeprex (codeine polistirex and chlorpheniramine polistirex) Extended-Release Suspension is a pink to purple-pink colored, cherry-cream flavored suspension, available in an amber colored plastic bottle for oral use only.

      NDC 53014-826-67  473 mL bottle

Shake well. Dispense in a well-closed container, and protect from light. Store at controlled room temperature not to exceed 25°C (77°F). Keep out of the reach of children.

Celltech Pharmaceuticals, Inc.
Rochester, NY 14623 USA

CODEPREX is a trademark of Celltech Pharmaceuticals, Inc.
PENNKINETIC is a registered trademark of Celltech Manufacturing, Inc.
Codeprex™ Pennkinetic® Extended-Release Suspension: US Patent No. 5,980,882.
© 2004, Celltech Pharmaceuticals, Inc. All rights reserved.
Rev. 6/04
LR428

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017